Leanne G. Caret
Known title: DirectorCIK: 0001668346
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Boeing (BA) Nears FAA Approval for 737 MAX 10 Amid New Jet Talks. The Federal Aviation Administration is close to approving the Boeing 737 MAX 10, which could expand the company's commercial jet lineup. At the same time, Boeing is in discussions to supply up to 50 additional wide‑body aircraft, indicating ongoing demand for its larger planes. Analysts note that a recent price‑target reduction by RBC reflects lingering uncertainty over defense spending, adding a mixed backdrop for the stock.
Transaction History
| DE | ▲ Buy | Grant | 293 | $0 | 3/4/2026 | View on chart |
| DE | ▲ Buy | Grant | 385 | $0 | 3/5/2025 | View on chart |
| DE | ▲ Buy | Grant | 450 | $0 | 3/6/2024 | View on chart |
| DE | ▲ Buy | Grant | 393 | $0 | 3/1/2023 | View on chart |
| DE | ▲ Buy | Grant | 425 | $0 | 3/2/2022 | View on chart |
| BA | ▼ Sell | Tax Withholding | 6,647 | $1.3M | 2/28/2022 | View on chart |
| BA | ▼ Sell | Tax Withholding | 631 | $127K | 2/25/2022 | View on chart |
| BA | ▲ Buy | Grant | 10,921 | $0 | 2/16/2022 | View on chart |
| DE | ▲ Buy | Grant | 144 | $0 | 11/1/2021 | View on chart |
| BA | ▼ Sell | Tax Withholding | 106 | $22K | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Deere Faces Federal Scrutiny Amid Market Volatility
Deere & Company is currently under federal scrutiny, a development that has drawn significant investor attention. While one analysis suggests the stock may be undervalued following this review, the company recently experienced a larger drop than the general market. The stock is currently trading near its support level, reflecting mixed sentiment among investors.
Deere Faces Federal Scrutiny Amid Market Volatility. Deere & Company is currently under federal scrutiny, a development that has drawn significant investor attention. While one analysis suggests the stock may be undervalued following this review, the company recently experienced a larger drop than the general market. The stock is currently trading near its support level, reflecting mixed sentiment among investors.